IMR Press / FBL / Special Issues / gut_dysbiosis_associated_disease

Gut Dysbiosis-Associated Diseases: Unraveling the "Gut-Other Axes" in Non-Communicable Diseases

Submission deadline: 10 April 2023
Special Issue Editor
  • Emanuele Rinninella, MD, PhD
    Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore - Sede di Roma, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRRCS – Roma, Italy
    Interests: clinical nutrition; gut microbiota; oncology; ERAS (Enhanced Recovery After Surgery)
Special Issue Information

Dear Colleagues,

In the last two decades, the “microbiota revolution” has profoundly changed our knowledge in several fields of medicine, offering preclinical and translational evidence on the intriguing network between gut microbiota, inflammation, autoimmunity, and non-communicable diseases. The gut microbiota is now considered a complex organ, at the crossroads of many systems, and involved in both physiological and pathological processes. Therefore, it can be approached as a new model of scientific research and clinical management. In addition, since the microbiota composition is partially modulated by external factors (such as diet, pre-and probiotics, lifestyle, drugs, etc.) this complex organ can be properly preserved and restored when necessary.

Several new organ axes have recently been discovered, including the gut-liver, gut-brain, gut-eye, gut-joint, and gut-muscle axis. The aims of this Special Issue “Gut dysbiosis-associated diseases:unraveling the “gut-other axes” in non-communicable diseases” is to go in-depth into this landscape and offer a broader and complete vision of this subject. This Special Issues is being hosted by Frontiers in Bioscience-Landmark. Original papers, review articles, systematic reviews, and meta-analyses with translational significance are welcomed for this project.

Dr. Emanuele Rinninella

Guest Editor

Keywords
gut microbiota
cross-mimicry
autoimmunity
inflammation
diet
prebiotics
probiotics
lifestyle
neurodegenerative diseases
liver diseases
inflammatory bowel diseases (IBDs)
obesity
metabolic diseases
diabetes
cardiovascular diseases
cancer
sarcopenia
eye diseases
joint diseases
skin diseases
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Back to top